Multiscale model for the assessment of autonomic dysfunction in human endotoxemia

Physiological Genomics

Volumn 42, Issue 1, 2010, Pages 5-19

  Foteinou, Panagiota T ^a   Calvano, Steve E ^b   Lowry, Stephen F ^b   Androulakis, Ioannis P ^a  

^a RUTGERS UNIVERSITY   (United States)

^b ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Endotoxin; Heart rate variability; Inflammation; Modeling

Indexed keywords

ADRENALIN; HYDROCORTISONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; STRESS HORMONE;

ADRENALIN BLOOD LEVEL; ARTICLE; AUTONOMIC DYSFUNCTION; CONTROLLED STUDY; ENDOTOXEMIA; HEART RATE VARIABILITY; HUMAN; HUMAN EXPERIMENT; HYDROCORTISONE BLOOD LEVEL; HYPERCORTISOLISM; IMMUNE RESPONSE; MATHEMATICAL ANALYSIS; MATHEMATICAL MODEL; MATHEMATICAL PARAMETERS; PHENOTYPE; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; SIGNAL TRANSDUCTION; SIMULATION; TRANSCRIPTION REGULATION;

ADRENAL CORTEX HORMONES; ALGORITHMS; AUTONOMIC NERVOUS SYSTEM; ENDOTOXEMIA; ENDOTOXINS; EPINEPHRINE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HEART RATE; HUMANS; HYDROCORTISONE; INFLAMMATION; LIPOPOLYSACCHARIDES; MODELS, BIOLOGICAL;

EID: 77953214777     PISSN: 10948341     EISSN: 15312267     Source Type: Journal    
DOI: 10.1152/physiolgenomics.00184.2009     Document Type: Article

References (82)

1. Aldridge BB, Burke JM, Lauffenburger DA, Sorger PK. Physicochemical modelling of cell signalling pathways. Nat Cell Biol 8: 1195-1203, 2006.
2. Alvarez SM, Katsamanis Karavidas M, Coyle SM, Lu SE, Macor M, Oikawa LO, Lehrer PM, Calvano SE, Lowry SF. Low-dose steroid alters in vivo endotoxin-induced systemic inflammation but does not influence autonomic dysfunction. J Endotoxin Res 13: 358-368, 2007.
3. An G. Introduction of an agent-based multi-scale modular architecture for dynamic knowledge representation of acute inflammation. Theor Biol Med Model 5: 11, 2008.
4. An G, Faeder J, Vodovotz Y. Translational systems biology: introduction of an engineering approach to the pathophysiology of the burn patient. J Burn Care Res 29: 277-285, 2008.
5. Andreasen AS, Krabbe KS, Krogh-Madsen R, Taudorf S, Pedersen BK, Moller K. Human endotoxemia as a model of systemic inflammation. Curr Med Chem 15: 1697-1705, 2008.
6. Aronson D, Mittleman MA, Burger AJ. Interleukin-6 levels are inversely correlated with heart rate variability in patients with decompensated heart failure. J Cardiovasc Electrophysiol 12: 294-300, 2001. (Pubitemid 32225457)
7. Barber AE, Coyle SM, Marano MA, Fischer E, Calvano SE, Fong Y, Moldawer LL, Lowry SF. Glucocorticoid therapy alters hormonal and cytokine responses to endotoxin in man. J Immunol 150: 1999-2006, 1993.
8. Barnes PJ, Karin M. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 336: 1066-1071, 1997.
9. Bendixen HH, Osgood PF, Hall KV, Laver MB. Dose-dependent differences in catecholamine action on heart and periphery. J Pharmacol Exp Ther 145: 299-306, 1964.
10. Berntson GG, Bigger JT Jr, Eckberg DL, Grossman P, Kaufmann PG, Malik M, Nagaraja HN, Porges SW, Saul JP, Stone PH, van der Molen MW. Heart rate variability: origins, methods, and interpretive caveats. Psychophysiology 34: 623-648, 1997. (Pubitemid 27514918)
11. Berntson GG, Cacioppo JT, Quigley KS. Autonomic determinism: the modes of autonomic control, the doctrine of autonomic space, and the laws of autonomic constraint. Psychol Rev 98: 459-487, 1991.
12. Blalock JE. Harnessing a neural-immune circuit to control inflammation and shock. J Exp Med 195: F25-F28, 2002.
13. Borovikova LV, Ivanova S, Zhang M, Yang H, Botchkina GI, Watkins LR, Wang H, Abumrad N, Eaton JW, Tracey KJ. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 405: 458-462, 2000.
14. Brown GL, Eccles JC. The action of a single vagal volley on the rhythm of the heart beat. J Physiol 82: 211-241, 1934.
15. Calvano SE, Xiao W, Richards DR, Felciano RM, Baker HV, Cho RJ, Chen RO, Brownstein BH, Cobb JP, Tschoeke SK, Miller-Graziano C, Moldawer LL, Mindrinos MN, Davis RW, Tompkins RG, Lowry SF; Inflamm and Host Response to Injury Large Scale Collab Res. Program. A network-based analysis of systemic inflammation in humans. Nature 437: 1032-1037, 2005.
16. Cavaillon JM, Annane D. Compartmentalization of the inflammatory response in sepsis and SIRS. J Endotoxin Res 12: 151-170, 2006.
17. Chow CC, Clermont G, Kumar R, Lagoa C, Tawadrous Z, Gallo D, Betten B, Bartels J, Constantine G, Fink MP, Billiar TR, Vodovotz Y. The acute inflammatory response in diverse shock states. Shock 24: 74-84, 2005.
18. Chrousos GP. The hypothalamic-pituitary-adrenal axis and immunemediated inflammation. N Engl J Med 332: 1351-1362, 1995.
19. Clermont G, Bartels J, Kumar R, Constantine G, Vodovotz Y, Chow C. In silico design of clinical trials: a method coming of age. Crit Care Med 32: 2061-2070, 2004.
20. Cobb JP, Mindrinos MN, Miller-Graziano C, Calvano SE, Baker HV, Xiao W, et al.; Inflammation and Host Response to Injury Large-Scale Collaborative Research Program. Application of genome-wide expression analysis to human health and disease. Proc Natl Acad Sci USA 102: 4801-4806, 2005.
21. Contreras M, Ryan LM. Fitting nonlinear and constrained generalized estimating equations with optimization software. Biometrics 56: 1268-1271, 2000.
22. Copeland S, Warren HS, Lowry SF, Calvano SE, Remick D. Acute inflammatory response to endotoxin in mice and humans. Clin Diagn Lab Immunol 12: 60-67, 2005.
23. Costa M, Goldberger AL, Peng CK. Multiscale entropy analysis of complex physiologic time series. Phys Rev Lett 89: 068102, 2002.
24. Court O, Kumar A, Parrillo JE, Kumar A. Clinical review: myocardial depression in sepsis and septic shock. Crit Care 6: 500-508, 2002.
25. Czura CJ, Tracey KJ. Autonomic neural regulation of immunity. J Intern Med 257: 156-166, 2005.
26. Dayneka NL, Garg V, Jusko WJ. Comparison of four basic models of indirect pharmacodynamic responses. J Pharmacokinet Biopharm 21: 457-478, 1993.
27. Elenkov IJ, Wilder RL, Chrousos GP, Vizi ES. The sympathetic nerve-an integrative interface between two supersystems: the brain and the immune system. Pharmacol Rev 52: 595-638, 2000.
28. Fannin RD, Auman JT, Bruno ME, Sieber SO, Ward SM, Tucker CJ, Merrick BA, Paules RS. Differential gene expression profiling in whole blood during acute systemic inflammation in lipopolysaccharide-treated rats. Physiol Genomics 21: 92-104, 2005.
29. Foteinou PT, Calvano SE, Lowry SF, Androulakis IP. An indirect response model of endotoxin-induced systemic inflammation. J Crit Care 22: 337-338, 2007.
30. Foteinou PT, Calvano SE, Lowry SF, Androulakis IP. In silico simulation of corticosteroids effect on an NFκB-dependent physicochemical model of systemic inflammation. PLoS One 4: e4706, 2009.
31. Foteinou PT, Calvano SE, Lowry SF, Androulakis IP. Modeling endotoxin-induced systemic inflammation using an indirect response approach. Math Biosci 217: 27-42, 2009.
32. Foteinou PT, Calvano SE, Lowry SF, Androulakis IP. Translational potential of systems-based models of inflammation. Clin Transl Sci 2: 85-89, 2009.
33. Godin PJ, Buchman TG. Uncoupling of biological oscillators: a complementary hypothesis concerning the pathogenesis of multiple organ dysfunction syndrome. Crit Care Med 24: 1107-1116, 1996.
34. Godin PJ, Fleisher LA, Eidsath A, Vandivier RW, Preas HL, Banks SM, Buchman TG, Suffredini AF. Experimental human endotoxemia increases cardiac regularity: results from a prospective, randomized, cross-over trial. Crit Care Med 24: 1117-1124, 1996.
35. Gutkin BS, Dehaene S, Changeux JP. A neurocomputational hypothesis for nicotine addiction. Proc Natl Acad Sci USA 103: 1106-1111, 2006.
36. Hasko G, Elenkov IJ, Kvetan V, Vizi ES. Differential effect of selective block of alpha 2-adrenoreceptors on plasma levels of tumour necrosis factor-alpha, interleukin-6 and corticosterone induced by bacterial lipopolysaccharide in mice. J Endocrinol 144: 457-462, 1995.
37. Hoffmann A, Levchenko A, Scott ML, Baltimore D. The IkappaB-NFkappaB signaling module: temporal control and selective gene activation. Science 298: 1241-1245, 2002.
38. Huikuri HV, Makikallio T, Airaksinen KE, Mitrani R, Castellanos A, Myerburg RJ. Measurement of heart rate variability: a clinical tool or a research toy? J Am Coll Cardiol 34: 1878-1883, 1999.
39. Ignatowski TA, Spengler RN. Regulation of macrophage-derived tumor necrosis factor production by modification of adrenergic receptor sensitivity. J Neuroimmunol 61: 61-70, 1995.
40. Jan BU, Coyle SM, Oikawa LO, Lu SE, Calvano SE, Lehrer PM, Lowry SF. Influence of acute epinephrine infusion on endotoxin-induced parameters of heart rate variability: a randomized controlled trial. Ann Surg 249: 750-756, 2009.
41. Jin JY, Almon RR, DuBois DC, Jusko WJ. Modeling of corticosteroid pharmacogenomics in rat liver using gene microarrays. J Pharmacol Exp Ther 307: 93-109, 2003.
42. Jusko WJ, Ko HC. Physiologic indirect response models characterize diverse types of pharmacodynamic effects. Clin Pharmacol Ther 56: 406-419, 1994.
43. Krishnamoorthy S, Honn KV. Inflammation and disease progression. Cancer Metastasis Rev 25: 481-491, 2006.
44. Lameris TW, de Zeeuw S, Duncker DJ, Tietge W, Alberts G, Boomsma F, Verdouw PD, van den Meiracker AH. Epinephrine in the heart: uptake and release, but no facilitation of norepinephrine release. Circulation 106: 860-865, 2002.
45. Lin E, Calvano SE, Coyle SM, Lowry SF. Physiologic hypercortisolemia in humans modulates CD95-signal transduction. Surg Forum 50: 288-290, 1999.
46. Lin E, Lowry SF. The human response to endotoxin. Sepsis 2: 255-262, 1998.
47. Lowry SF. Human endotoxemia: a model for mechanistic insight and therapeutic targeting. Shock 24, Suppl 1: 94-100, 2005.
48. Lowry SF, Calvano SE. Challenges for modeling and interpreting the complex biology of severe injury and inflammation. J Leukoc Biol 83: 553-557, 2008.
49. Mager DE, Jusko WJ. Pharmacodynamic modeling of time-dependent transduction systems. Clin Pharmacol Ther 70: 210-216, 2001.
50. Mager DE, Lin SX, Blum RA, Lates CD, Jusko WJ. Dose equivalency evaluation of major corticosteroids: pharmacokinetics and cell trafficking and cortisol dynamics. J Clin Pharmacol 43: 1216-1227, 2003.
51. Mager DE, Wyska E, Jusko WJ. Diversity of mechanism-based pharmacodynamic models. Drug Metab Dispos 31: 510-518, 2003.
52. Malave HA, Taylor AA, NATTAMA J, Deswal A, Mann DL. Circulating levels of tumor necrosis factor correlate with indexes of depressed heart rate variability: a study in patients with mild-to-moderate heart failure. Chest 123: 716-724, 2003.
53. Marsland AL, Gianaros PJ, Prather AA, Jennings JR, Neumann SA, Manuck SB. Stimulated production of proinflammatory cytokines covaries inversely with heart rate variability. Psychosom Med 69: 709-716, 2007.
54. Morris JA Jr, Norris PR, Ozdas A, Waitman LR, Harrell FE Jr, Williams AE, Cao H, Jenkins JM. Reduced heart rate variability: an indicator of cardiac uncoupling and diminished physiologic reserve in 1,425 trauma patients. J Trauma 60: 1165-1173, 2006.
55. Morris JA Jr, Norris PR, Waitman LR, Ozdas A, Guillamondegui OD, Jenkins JM. Adrenal insufficiency, heart rate variability, and complex biologic systems: a study of 1,871 critically ill trauma patients. J Am Coll Surg 204: 885-892, 2007.
56. Norris PR, Morris JA Jr, Ozdas A, Grogan EL, Williams AE. Heart rate variability predicts trauma patient outcome as early as 12 h: implications for military and civilian triage. J Surg Res 129: 122-128, 2005.
57. Norris PR, Ozdas A, Cao H, Williams AE, Harrell FE, Jenkins JM, Morris JA Jr. Cardiac uncoupling and heart rate variability stratify ICU patients by mortality: a study of 2088 trauma patients. Ann Surg 243: 804-812, 2006. (Pubitemid 44297488)
58. Norris PR, Stein PK, Morris JA Jr. Reduced heart rate multiscale entropy predicts death in critical illness: a study of physiologic complexity in 285 trauma patients. J Crit Care 23: 399-405, 2008.
59. Padgett DA, Glaser R. How stress influences the immune response. Trends Immunol 24: 444-448, 2003.
60. Prabhakar U, Conway TM, Murdock P, Mooney JL, Clark S, Hedge P, Bond BC, Jazwinska EC, Barnes MR, Tobin F, Damian-Iordachi V, Greller L, Hurle M, Stubbs AP, Li Z, Valoret EI, Erickson-Miller C, Cass L, Levitt B, Davis HM, Jorkasky DK, Williams WV. Correlation of protein and gene expression profiles of inflammatory proteins after endotoxin challenge in human subjects. DNA Cell Biol 24: 410-431, 2005.
61. Rassias AJ, Holzberger PT, Givan AL, Fahrner SL, Yeager MP. Decreased physiologic variability as a generalized response to human endotoxemia. Crit Care Med 33: 512-519, 2005.
62. Reyes WJ, Brimioulle S, Vincent JL. Septic shock without documented infection: an uncommon entity with a high mortality. Intensive Care Med 25: 1267-1270, 1999.
63. Seely AJ, Christou NV. Multiple organ dysfunction syndrome: exploring the paradigm of complex nonlinear systems. Crit Care Med 28: 2193-2200, 2000.
64. Sharma A, Jusko WJ. Characteristics of indirect pharmacodynamic models and applications to clinical drug responses. Br J Clin Pharmacol 45: 229-239, 1998.
65. Sharshar T, Hopkinson NS, Orlikowski D, Annane D. Science review: The brain in sepsis- culprit and victim. Crit Care 9: 37-44, 2005.
66. Stein PK, Kleiger RE. Insights from the study of heart rate variability. Annu Rev Med 50: 249-261, 1999.
67. Storey JD, Xiao W, Leek JT, Tompkins RG, Davis RW. Significance analysis of time course microarray experiments. Proc Natl Acad Sci USA 102: 12837-12842, 2005.
68. Sun YN, Jusko WJ. Transit compartments versus gamma distribution function to model signal transduction processes in pharmacodynamics. J Pharm Sci 87: 732-737, 1998.
69. Talwar S, Munson PJ, Barb J, Fiuza C, Cintron AP, Logun C, Tropea M, Khan S, Reda D, Shelhamer JH, Danner RL, Suffredini AF. Gene expression profiles of peripheral blood leukocytes after endotoxin challenge in humans. Physiol Genomics 25: 203-215, 2006.
70. Tracey KJ. The inflammatory reflex. Nature 420: 853-859, 2002.
71. Van der Poll T. Effects of catecholamines on the inflammatory response. Sepsis 4: 159-167, 2000.
72. Van der Poll T, Barber AE, Coyle SM, Lowry SF. Hypercortisolemia increases plasma interleukin-10 concentrations during human endotoxemia-a clinical research center study. J Clin Endocrinol Metab 81: 3604-3606, 1996.
73. Van der Poll T, Coyle SM, Barbosa K, Braxton CC, Lowry SF. Epinephrine inhibits tumor necrosis factor-alpha and potentiates interleukin 10 production during human endotoxemia. J Clin Invest 97: 713-719, 1996. (Pubitemid 26057090)
74. Van der Poll T, Lowry SF. Epinephrine inhibits endotoxin-induced IL-1 beta production: roles of tumor necrosis factor-alpha and IL-10. Am J Physiol Regul Integr Comp Physiol 273: R1885-R1890, 1997. (Pubitemid 127752089)
75. Vodovotz Y, Constantine G, Rubin J, Csete M, Voit EO, An G. Mechanistic simulations of inflammation: current state and future prospects. Math Biosci 2008.
76. Vodovotz Y, Csete M, Bartels J, Chang S, An G. Translational systems biology of inflammation. PLoS Comput Biol 4: e1000014, 2008.
77. Webster JI, Tonelli L, Sternberg EM. Neuroendocrine regulation of immunity. Annu Rev Immunol 20: 125-163, 2002.
78. Wells CA, Ravasi T, Hume DA. Inflammation suppressor genes: please switch out all the lights. J Leukoc Biol 78: 9-13, 2005.
79. Winchell RJ, Hoyt DB. Spectral analysis of heart rate variability in the ICU: a measure of autonomic function. J Surg Res 63: 11-16, 1996.
80. Winchell RJ, Hoyt DB. Analysis of heart-rate variability: a noninvasive predictor of death and poor outcome in patients with severe head injury. J Trauma 43: 927-933, 1997.
81. Wittebole X, Hahm S, Coyle SM, Kumar A, Calvano SE, Lowry SF. Nicotine exposure alters in vivo human responses to endotoxin. Clin Exp Immunol 147: 28-34, 2007.
82. Zaza A, Lombardi F. Autonomic indexes based on the analysis of heart rate variability: a view from the sinus node. Cardiovasc Res 50: 434-442, 2001.